Infectious Diseases and Clinical Microbiology

Doç. Dr. Sibel Bolukçu

Doctor and researcher Kartal Dr. Lütfi Kırdar Şehir Hastanesi İstanbul
HIV InfectionsBrucellosisCOVID-19Community-Acquired Infections

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • HIV Infections 7 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Brucellosis 5 publications
  • COVID-19 2 publications
  • Community-Acquired Infections 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyInfectious Diseases and Clinical Microbiologysaglik.gov.trFrom source
  • Department name at the sourceEnfeksiyon Hastalıklarısaglik.gov.trFrom source
  • InstitutionKartal Dr. Lütfi Kırdar Şehir Hastanesisaglik.gov.trFrom source
  • Area of workHIV InfectionsExtracted from 7 publications · Model version —From source
  • Publications50 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0001-6475-3894ORCIDFrom source
  • Last synchronised5 November 2026 08:56https://lutfikirdareah.saglik.gov.tr/TR-1476160/doktorlarimiz.html#sibel-bolukcusaglik.gov.tr

Scientific work

Publications on HIV Infections

50 publications
  1. Candidemia in Türkiye demonstrates nationwide predominance of non-albicans Candida and Candida auris detection

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-53506-3 PMID 42218233 Open-access full textSource: ORCID

  2. COVID‐19 Incidence and Factors Influencing Infection Risk Among People Living With HIV in Türkiye: Is Current Issue the Vaccine Hesitancy‐Opposition?

    Canadian Journal of Infectious Diseases and Medical Microbiology, 2025

    DOI 10.1155/cjid/6767853 PMID 40860331 Open-access full textSource: ORCID

  3. Cancer prevalence and prognosis among individuals living with HIV and AIDS in Turkey: Multicenter BUHASDER study

    International Journal of STD & AIDS, 2025

    DOI 10.1177/09564624251405965 PMID 41353610 Open-access full textSource: OpenAlex

  4. Future Directions in Sepsis Research: From Translational Science to Clinical Trials

    2025

    DOI 10.59537/saupress.2504 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  5. Investigation of Factors Affecting IgG Antibody Response in COVID-19 Cases

    Klimik Dergisi, 2024

    DOI 10.36519/kd.2024.4781 Open-access full textSource: ORCID

  6. Factors Influencing HIV Infection in Children Born to HIV-Infected Mothers in Turkey

    Balkan Medical Journal, 2023

    DOI 10.4274/balkanmedj.galenos.2023.2023-3-12 PMID 37350727 4 citations (Europe PMC) Open-access full textSource: ORCID

  7. Treatment of COVID-19: Antivirals, Antibody Products, Immunomodulators, Antithrombotic Therapy, and Supplements

    Cam and Sakura Medical Journal, 2023

    DOI 10.4274/csmedj.galenos.2022.2022-12-1 Open-access full textSource: OpenAlex

  8. SARS-CoV-2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two-dose CoronaVac vaccine regimen

    Journal of Medical Virology, 2022

    DOI 10.1002/jmv.27350 PMID 34536028 50 citations (Europe PMC) Source: ORCID

  9. Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls

    Rheumatology International, 2021

    DOI 10.1007/s00296-021-04965-6 PMID 34515808 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  10. The effects of polypharmacy, nutritional and functional status on the progression of COVID-19 in older adults

    Infectious Diseases and Clinical Microbiology, 2021

    DOI 10.36519/idcm.2021.60 Open-access full textSource: OpenAlex

View all 50 publications